Titlebook: Clostridioides difficile; Infections, Risk Fac Henning Sommermeyer,Jacek Pi?tek Book 2021 The Editor(s) (if applicable) and The Author(s),

formation

書目名稱Clostridioides difficile影響因子(影響力)




書目名稱Clostridioides difficile影響因子(影響力)學(xué)科排名




書目名稱Clostridioides difficile網(wǎng)絡(luò)公開度




書目名稱Clostridioides difficile網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Clostridioides difficile被引頻次




書目名稱Clostridioides difficile被引頻次學(xué)科排名




書目名稱Clostridioides difficile年度引用




書目名稱Clostridioides difficile年度引用學(xué)科排名




書目名稱Clostridioides difficile讀者反饋




書目名稱Clostridioides difficile讀者反饋學(xué)科排名

evince

結(jié)束

https://doi.org/10.1007/978-3-662-02617-5e and vancomycin are still the antibiotics of choice for treating CDI; however, the first . strains with a reduced susceptibility against these antibiotics have been encountered. Supporting the colonization resistance associated with a diverse and balanced gut microbiota is most likely the best prot

mastoid-bone

Book 2021 difficile. helps the reader gain a better understanding of C. difficile, the challenges that may arise and the available treatment options. Given its broad coverage and features, it will appeal to a wide readership, from gastroenterologists through general physicians, nurses, and other healthcare p

entice

Epidemiology,on which inactivated a negative regulator of the toxin production (tcdC) in the pathogenicity locus. Over the last years a large number of different ribotypes of . have been identified by international surveillance programs. Recurrence of CDI is occurring in 10–25% of patients after a primary infect

construct

Treatment of CDI,a has been claimed to provide the best protection against CDI, resulting in the suggestion to support the gut microbiota with products containing probiotic bacteria (probiotics or synbiotics). Despite positive reports, clinical evidence is still slim to support a recommendation of these products for

construct

Summary and Discussion,e and vancomycin are still the antibiotics of choice for treating CDI; however, the first . strains with a reduced susceptibility against these antibiotics have been encountered. Supporting the colonization resistance associated with a diverse and balanced gut microbiota is most likely the best prot

大都市

Mindfulness

Diagnosis of CDI,on of the .-specific glutamate dehydrogenase (GDH) and toxins (TcdA and/or TcdB) in feces using enzyme immune assays (EIAs). Nucleic acid amplification tests (NAAT) are used to detect .-specific genes (16 rRNA, GDH) and the toxin genes (tcdA and tcdB). Diagnosis of CDI is employing either a two-step or a three-step algorithm.

Accolade

https://doi.org/10.1007/978-3-642-88138-1on of the .-specific glutamate dehydrogenase (GDH) and toxins (TcdA and/or TcdB) in feces using enzyme immune assays (EIAs). Nucleic acid amplification tests (NAAT) are used to detect .-specific genes (16 rRNA, GDH) and the toxin genes (tcdA and tcdB). Diagnosis of CDI is employing either a two-step or a three-step algorithm.